Skip to main content
Erschienen in: Tumor Biology 12/2014

01.12.2014 | Research Article

The association between the polymorphisms of TNF-α and non-Hodgkin lymphoma: a meta-analysis

verfasst von: Yong-Qiao He, Jin-Hong Zhu, Shao-Yi Huang, Zhuo Cui, Jing He, Wei-Hua Jia

Erschienen in: Tumor Biology | Ausgabe 12/2014

Einloggen, um Zugang zu erhalten

Abstract

Many genetic variations in the promoter region of tumor necrosis factor alpha (TNF-α) may confer host susceptibility to cancer by influencing TNF-α expression. Nevertheless, the results remain inconclusive. The current meta-analysis was performed to investigate the association between three common TNF-α promoter polymorphisms and the risk of non-Hodgkin lymphoma (NHL). A literature search was conducted mainly from PubMed for all eligible studies. The pooled odds ratios (ORs) and corresponding 95 % confidence intervals (CIs) were used to assess the association of TNF-α polymorphisms with the risk of NHL. TNF-α −308 A allele showed a statistically significant increased risk for NHL under the homozygous (AA vs. GG, OR = 1.51, 95 % CI = 1.26–1.80) and recessive (OR = 1.47, 95 % CI = 1.23–1.75) models, respectively. The stratified analyses showed an increased risk of NHL with the presence of TNF-α −308 A allele among Africans and Caucasians, but a decreased risk among Asians. No association was observed between −238 G/A polymorphism and NHL risk either in the overall analysis or in the stratified analysis. Similarly, pooled analysis did not reveal an altered risk of NHL with −857 C/T polymorphism. Nonetheless, a statistically significant association was observed among Asians when stratified by ethnicity. Among the three genetic variations of interest, TNF-α −308 G/A polymorphism was significantly associated with the risk of NHL; neither −238 G/A nor −857 C/T polymorphism was shown to alter the overall NHL risk; however, stratified analysis by ethnicity observed a statistically significant association between −857 C/T polymorphism and the risk of NHL among Asians.
Literatur
1.
Zurück zum Zitat Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin. 2014;64:9–29.PubMed Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin. 2014;64:9–29.PubMed
2.
Zurück zum Zitat Fears SSDaT (1992) Non-Hodgkin’s lymphoma time trends: United States and international data. Fears SSDaT (1992) Non-Hodgkin’s lymphoma time trends: United States and international data.
3.
Zurück zum Zitat Cartwright R, Brincker H, Carli PM, Clayden D, Coebergh JW, et al. The rise in incidence of lymphomas in Europe 1985–1992. Eur J Cancer. 1999;35:627–33.PubMed Cartwright R, Brincker H, Carli PM, Clayden D, Coebergh JW, et al. The rise in incidence of lymphomas in Europe 1985–1992. Eur J Cancer. 1999;35:627–33.PubMed
4.
Zurück zum Zitat K. N. Naresh VSCSS (2000) Distribution of various subtypes of non-Hodgkin’s lymphoma in India: a study of 2773 lymphomas using R.E.A.L. and WHO classifications. K. N. Naresh VSCSS (2000) Distribution of various subtypes of non-Hodgkin’s lymphoma in India: a study of 2773 lymphomas using R.E.A.L. and WHO classifications.
5.
Zurück zum Zitat Smedby KE, Hjalgrim H. Epidemiology and etiology of mantle cell lymphoma and other non-Hodgkin lymphoma subtypes. Semin Cancer Biol. 2011;21:293–8.PubMed Smedby KE, Hjalgrim H. Epidemiology and etiology of mantle cell lymphoma and other non-Hodgkin lymphoma subtypes. Semin Cancer Biol. 2011;21:293–8.PubMed
6.
Zurück zum Zitat Grulich AE, Vajdic CM, Cozen W. Altered immunity as a risk factor for non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev. 2007;16:405–8.PubMed Grulich AE, Vajdic CM, Cozen W. Altered immunity as a risk factor for non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev. 2007;16:405–8.PubMed
7.
Zurück zum Zitat Silverberg MJ, Chao C, Leyden WA, Xu L, Horberg MA, et al. HIV infection, immunodeficiency, viral replication, and the risk of cancer. Cancer Epidemiol Biomarkers Prev. 2011;20:2551–9.PubMedPubMedCentral Silverberg MJ, Chao C, Leyden WA, Xu L, Horberg MA, et al. HIV infection, immunodeficiency, viral replication, and the risk of cancer. Cancer Epidemiol Biomarkers Prev. 2011;20:2551–9.PubMedPubMedCentral
8.
Zurück zum Zitat van Leeuwen MT, Grulich AE, Webster AC, McCredie MR, Stewart JH, et al. Immunosuppression and other risk factors for early and late non-Hodgkin lymphoma after kidney transplantation. Blood. 2009;114:630–7.PubMed van Leeuwen MT, Grulich AE, Webster AC, McCredie MR, Stewart JH, et al. Immunosuppression and other risk factors for early and late non-Hodgkin lymphoma after kidney transplantation. Blood. 2009;114:630–7.PubMed
9.
Zurück zum Zitat Balkwill F (2002) Tumor necrosis factor or tumor promoting factor? Balkwill F (2002) Tumor necrosis factor or tumor promoting factor?
10.
Zurück zum Zitat Ardizzoia A, Lissoni P, Brivio F, Tisi E, Perego MS, et al. Tumor necrosis factor in solid tumors: increased blood levels in the metastatic disease. J Biol Regul Homeost Agents. 1992;6:103–7.PubMed Ardizzoia A, Lissoni P, Brivio F, Tisi E, Perego MS, et al. Tumor necrosis factor in solid tumors: increased blood levels in the metastatic disease. J Biol Regul Homeost Agents. 1992;6:103–7.PubMed
11.
Zurück zum Zitat Warzocha K, Salles G, Bienvenu J, Bastion Y, Dumontet C, et al. Tumor necrosis factor ligand-receptor system can predict treatment outcome in lymphoma patients. J Clin Oncol. 1997;15:499–508.PubMed Warzocha K, Salles G, Bienvenu J, Bastion Y, Dumontet C, et al. Tumor necrosis factor ligand-receptor system can predict treatment outcome in lymphoma patients. J Clin Oncol. 1997;15:499–508.PubMed
12.
Zurück zum Zitat Warzocha K, Salles G, Bienvenu J, Barbier Y, Bastion Y, et al. Prognostic significance of TNF alpha and its p55 soluble receptor in malignant lymphomas. Leukemia. 1997;11 Suppl 3:441–3.PubMed Warzocha K, Salles G, Bienvenu J, Barbier Y, Bastion Y, et al. Prognostic significance of TNF alpha and its p55 soluble receptor in malignant lymphomas. Leukemia. 1997;11 Suppl 3:441–3.PubMed
13.
Zurück zum Zitat Li D, Li G, Wang B. Serum tumor necrosis factor-alpha levels in non-Hodgkin’s lymphoma patients and its relationship to prognosis. Zhonghua Zhong Liu Za Zhi. 1997;19:293–6.PubMed Li D, Li G, Wang B. Serum tumor necrosis factor-alpha levels in non-Hodgkin’s lymphoma patients and its relationship to prognosis. Zhonghua Zhong Liu Za Zhi. 1997;19:293–6.PubMed
14.
Zurück zum Zitat Warzocha K, Ribeiro P, Bienvenu J, Roy P, Charlot C, et al. Genetic polymorphisms in the tumor necrosis factor locus influence non-Hodgkin’s lymphoma outcome. Blood. 1998;91:3574–81.PubMed Warzocha K, Ribeiro P, Bienvenu J, Roy P, Charlot C, et al. Genetic polymorphisms in the tumor necrosis factor locus influence non-Hodgkin’s lymphoma outcome. Blood. 1998;91:3574–81.PubMed
15.
Zurück zum Zitat Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci U S A. 1997;94:3195–9.PubMedPubMedCentral Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci U S A. 1997;94:3195–9.PubMedPubMedCentral
16.
Zurück zum Zitat Higuchi T, Seki N, Kamizono S, Yamada A, Kimura A, et al. Polymorphism of the 5′-flanking region of the human tumor necrosis factor (TNF)-alpha gene in Japanese. Tissue Antigens. 1998;51:605–12.PubMed Higuchi T, Seki N, Kamizono S, Yamada A, Kimura A, et al. Polymorphism of the 5′-flanking region of the human tumor necrosis factor (TNF)-alpha gene in Japanese. Tissue Antigens. 1998;51:605–12.PubMed
17.
Zurück zum Zitat Demeter J, Porzsolt F, Ramisch S, Schmid M, Messer G. Polymorphism of the tumour necrosis factor-alpha and lymphotoxin-alpha genes in hairy cell leukaemia. Br J Haematol. 1997;97:132–4.PubMed Demeter J, Porzsolt F, Ramisch S, Schmid M, Messer G. Polymorphism of the tumour necrosis factor-alpha and lymphotoxin-alpha genes in hairy cell leukaemia. Br J Haematol. 1997;97:132–4.PubMed
18.
Zurück zum Zitat Chouchane L, Ahmed SB, Baccouche S, Remadi S. Polymorphism in the tumor necrosis factor-alpha promotor region and in the heat shock protein 70 genes associated with malignant tumors. Cancer. 1997;80:1489–96.PubMed Chouchane L, Ahmed SB, Baccouche S, Remadi S. Polymorphism in the tumor necrosis factor-alpha promotor region and in the heat shock protein 70 genes associated with malignant tumors. Cancer. 1997;80:1489–96.PubMed
19.
Zurück zum Zitat Demeter J, Porzsolt F, Ramisch S, Schmidt D, Schmid M, et al. Polymorphism of the tumour necrosis factor-alpha and lymphotoxin-alpha genes in chronic lymphocytic leukaemia. Br J Haematol. 1997;97:107–12.PubMed Demeter J, Porzsolt F, Ramisch S, Schmidt D, Schmid M, et al. Polymorphism of the tumour necrosis factor-alpha and lymphotoxin-alpha genes in chronic lymphocytic leukaemia. Br J Haematol. 1997;97:107–12.PubMed
20.
Zurück zum Zitat Fitzgibbon J, Grenzelias D, Matthews J, Lister TA, Gupta RK. Tumour necrosis factor polymorphisms and susceptibility to follicular lymphoma. Br J Haematol. 1999;107:388–91.PubMed Fitzgibbon J, Grenzelias D, Matthews J, Lister TA, Gupta RK. Tumour necrosis factor polymorphisms and susceptibility to follicular lymphoma. Br J Haematol. 1999;107:388–91.PubMed
21.
Zurück zum Zitat Wihlborg C, Sjoberg J, Intaglietta M, Axdorph U, Pisa EK, et al. Tumour necrosis factor-alpha cytokine promoter gene polymorphism in Hodgkin’s disease and chronic lymphocytic leukaemia. Br J Haematol. 1999;104:346–9.PubMed Wihlborg C, Sjoberg J, Intaglietta M, Axdorph U, Pisa EK, et al. Tumour necrosis factor-alpha cytokine promoter gene polymorphism in Hodgkin’s disease and chronic lymphocytic leukaemia. Br J Haematol. 1999;104:346–9.PubMed
22.
Zurück zum Zitat Tsukasaki K, Miller CW, Kubota T, Takeuchi S, Fujimoto T, et al. Tumor necrosis factor alpha polymorphism associated with increased susceptibility to development of adult T-cell leukemia/lymphoma in human T-lymphotropic virus type 1 carriers. Cancer Res. 2001;61:3770–4.PubMed Tsukasaki K, Miller CW, Kubota T, Takeuchi S, Fujimoto T, et al. Tumor necrosis factor alpha polymorphism associated with increased susceptibility to development of adult T-cell leukemia/lymphoma in human T-lymphotropic virus type 1 carriers. Cancer Res. 2001;61:3770–4.PubMed
23.
Zurück zum Zitat Bogunia-Kubik K, Mazur G, Urbanowicz I, Wrobel T, Kuliczkowski K, et al. Lack of association between the TNF-alpha promoter gene polymorphism and susceptibility to B-cell chronic lymphocytic leukaemia. Int J Immunogenet. 2005;33:21–4. Bogunia-Kubik K, Mazur G, Urbanowicz I, Wrobel T, Kuliczkowski K, et al. Lack of association between the TNF-alpha promoter gene polymorphism and susceptibility to B-cell chronic lymphocytic leukaemia. Int J Immunogenet. 2005;33:21–4.
24.
Zurück zum Zitat Hellmig S, Fischbach W, Goebeler-Kolve ME, Folsch UR, Hampe J, et al. A functional promotor polymorphism of TNF-alpha is associated with primary gastric B-Cell lymphoma. Am J Gastroenterol. 2005;100:2644–9.PubMed Hellmig S, Fischbach W, Goebeler-Kolve ME, Folsch UR, Hampe J, et al. A functional promotor polymorphism of TNF-alpha is associated with primary gastric B-Cell lymphoma. Am J Gastroenterol. 2005;100:2644–9.PubMed
25.
Zurück zum Zitat Lan Q, Zheng T, Rothman N, Zhang Y, Wang SS, et al. Cytokine polymorphisms in the Th1/Th2 pathway and susceptibility to non-Hodgkin lymphoma. Blood. 2006;107:4101–8.PubMedPubMedCentral Lan Q, Zheng T, Rothman N, Zhang Y, Wang SS, et al. Cytokine polymorphisms in the Th1/Th2 pathway and susceptibility to non-Hodgkin lymphoma. Blood. 2006;107:4101–8.PubMedPubMedCentral
26.
Zurück zum Zitat Wang SS, Cerhan JR, Hartge P, Davis S, Cozen W, et al. Common genetic variants in proinflammatory and other immunoregulatory genes and risk for non-Hodgkin lymphoma. Cancer Res. 2006;66:9771–80.PubMed Wang SS, Cerhan JR, Hartge P, Davis S, Cozen W, et al. Common genetic variants in proinflammatory and other immunoregulatory genes and risk for non-Hodgkin lymphoma. Cancer Res. 2006;66:9771–80.PubMed
27.
Zurück zum Zitat Bel Hadj Jrad B, Chatti A, Laatiri A, Ahmed SB, Romdhane A, et al. Tumor necrosis factor promoter gene polymorphism associated with increased susceptibility to non-Hodgkin’s lymphomas. Eur J Haematol. 2007;78:117–22.PubMed Bel Hadj Jrad B, Chatti A, Laatiri A, Ahmed SB, Romdhane A, et al. Tumor necrosis factor promoter gene polymorphism associated with increased susceptibility to non-Hodgkin’s lymphomas. Eur J Haematol. 2007;78:117–22.PubMed
28.
Zurück zum Zitat Purdue MP, Lan Q, Kricker A, Grulich AE, Vajdic CM, et al. Polymorphisms in immune function genes and risk of non-Hodgkin lymphoma: findings from the New South Wales non-Hodgkin lymphoma study. Carcinogenesis. 2007;28:704–12.PubMed Purdue MP, Lan Q, Kricker A, Grulich AE, Vajdic CM, et al. Polymorphisms in immune function genes and risk of non-Hodgkin lymphoma: findings from the New South Wales non-Hodgkin lymphoma study. Carcinogenesis. 2007;28:704–12.PubMed
29.
Zurück zum Zitat Cerhan JR, Liu-Mares W, Fredericksen ZS, Novak AJ, Cunningham JM, et al. Genetic variation in tumor necrosis factor and the nuclear factor-kappaB canonical pathway and risk of non-Hodgkin’s lymphoma. Cancer Epidemiol Biomarkers Prev. 2008;17:3161–9.PubMedPubMedCentral Cerhan JR, Liu-Mares W, Fredericksen ZS, Novak AJ, Cunningham JM, et al. Genetic variation in tumor necrosis factor and the nuclear factor-kappaB canonical pathway and risk of non-Hodgkin’s lymphoma. Cancer Epidemiol Biomarkers Prev. 2008;17:3161–9.PubMedPubMedCentral
30.
Zurück zum Zitat Jevtovic-Stoimenov T, Kocic G, Pavlovic D, Macukanovic-Golubovic L, Marjanovic G, et al. Polymorphisms of tumor-necrosis factor-alpha −308 and lymphotoxin-alpha + 250: possible modulation of susceptibility to apoptosis in chronic lymphocytic leukemia and non-Hodgkin lymphoma mononuclear cells. Leuk Lymphoma. 2008;49:2163–9.PubMed Jevtovic-Stoimenov T, Kocic G, Pavlovic D, Macukanovic-Golubovic L, Marjanovic G, et al. Polymorphisms of tumor-necrosis factor-alpha −308 and lymphotoxin-alpha + 250: possible modulation of susceptibility to apoptosis in chronic lymphocytic leukemia and non-Hodgkin lymphoma mononuclear cells. Leuk Lymphoma. 2008;49:2163–9.PubMed
31.
Zurück zum Zitat Aissani B, Ogwaro KM, Shrestha S, Tang J, Breen EC, et al. The major histocompatibility complex conserved extended haplotype 8.1 in AIDS-related non-Hodgkin’s lymphoma. J Acquir Immune Defic Syndr. 2009;52:170–9.PubMedPubMedCentral Aissani B, Ogwaro KM, Shrestha S, Tang J, Breen EC, et al. The major histocompatibility complex conserved extended haplotype 8.1 in AIDS-related non-Hodgkin’s lymphoma. J Acquir Immune Defic Syndr. 2009;52:170–9.PubMedPubMedCentral
32.
Zurück zum Zitat Andrie E, Michos A, Kalampoki V, Pourtsidis A, Moschovi M, et al. Genetic variants in immunoregulatory genes and risk for childhood lymphomas. Eur J Haematol. 2009;83:334–42.PubMed Andrie E, Michos A, Kalampoki V, Pourtsidis A, Moschovi M, et al. Genetic variants in immunoregulatory genes and risk for childhood lymphomas. Eur J Haematol. 2009;83:334–42.PubMed
33.
Zurück zum Zitat Fernberg P, Chang ET, Duvefelt K, Hjalgrim H, Eloranta S, et al. Genetic variation in chromosomal translocation breakpoint and immune function genes and risk of non-Hodgkin lymphoma. Cancer Causes Control. 2010;21:759–69.PubMed Fernberg P, Chang ET, Duvefelt K, Hjalgrim H, Eloranta S, et al. Genetic variation in chromosomal translocation breakpoint and immune function genes and risk of non-Hodgkin lymphoma. Cancer Causes Control. 2010;21:759–69.PubMed
34.
Zurück zum Zitat Thunberg U, Enblad G, Turesson I, Berglund M. Genetic variation in tumor necrosis factor and risk of diffuse large B-cell lymphoma and follicular lymphoma: differences between subgroups in Swedish patients. Leuk Lymphoma. 2010;51:1563–6.PubMed Thunberg U, Enblad G, Turesson I, Berglund M. Genetic variation in tumor necrosis factor and risk of diffuse large B-cell lymphoma and follicular lymphoma: differences between subgroups in Swedish patients. Leuk Lymphoma. 2010;51:1563–6.PubMed
35.
Zurück zum Zitat Xiao H, Zhang K. Genetic polymorphisms of tumor necrosis factor-alpha and lymphotoxin-alpha in Chinese patients with non-Hodgkin lymphoma. Ann Hematol. 2010;90:725–7.PubMed Xiao H, Zhang K. Genetic polymorphisms of tumor necrosis factor-alpha and lymphotoxin-alpha in Chinese patients with non-Hodgkin lymphoma. Ann Hematol. 2010;90:725–7.PubMed
36.
Zurück zum Zitat Ibrahim A, Abdel Rahman H, Khorshied M, Sami R, Nasr N, et al. Tumor necrosis factor alpha−308 and lymphotoxin alpha + 252 genetic polymorphisms and the susceptibility to non-Hodgkin lymphoma in Egypt. Leuk Res. 2011;36:694–8.PubMed Ibrahim A, Abdel Rahman H, Khorshied M, Sami R, Nasr N, et al. Tumor necrosis factor alpha−308 and lymphotoxin alpha + 252 genetic polymorphisms and the susceptibility to non-Hodgkin lymphoma in Egypt. Leuk Res. 2011;36:694–8.PubMed
37.
Zurück zum Zitat Bi X, Zheng T, Lan Q, Xu Z, Chen Y, et al. Genetic polymorphisms in IL10RA and TNF modify the association between blood transfusion and risk of non-Hodgkin lymphoma. Am J Hematol. 2012;87:766–9.PubMedPubMedCentral Bi X, Zheng T, Lan Q, Xu Z, Chen Y, et al. Genetic polymorphisms in IL10RA and TNF modify the association between blood transfusion and risk of non-Hodgkin lymphoma. Am J Hematol. 2012;87:766–9.PubMedPubMedCentral
38.
Zurück zum Zitat Hosgood 3rd HD, Au WY, Kim HN, Liu J, Hu W, et al. IL10 and TNF variants and risk of non-Hodgkin lymphoma among three Asian populations. Int J Hematol. 2013;97:793–9.PubMedPubMedCentral Hosgood 3rd HD, Au WY, Kim HN, Liu J, Hu W, et al. IL10 and TNF variants and risk of non-Hodgkin lymphoma among three Asian populations. Int J Hematol. 2013;97:793–9.PubMedPubMedCentral
39.
Zurück zum Zitat Lech-Maranda E, Mlynarski W, Grzybowska-Izydorczyk O, Borowiec M, Pastorczak A, et al. Polymorphisms of TNF and IL-10 genes and clinical outcome of patients with chronic lymphocytic leukemia. Genes Chromosom Cancer. 2013;52:287–96.PubMed Lech-Maranda E, Mlynarski W, Grzybowska-Izydorczyk O, Borowiec M, Pastorczak A, et al. Polymorphisms of TNF and IL-10 genes and clinical outcome of patients with chronic lymphocytic leukemia. Genes Chromosom Cancer. 2013;52:287–96.PubMed
40.
Zurück zum Zitat Liu J, Song B, Wang T, Liu Y, Hao J, et al. Genetic variations in CTLA-4, TNF-alpha, and LTA and susceptibility to T-cell lymphoma in a Chinese population. Cancer Epidemiol. 2013;37:930–4.PubMed Liu J, Song B, Wang T, Liu Y, Hao J, et al. Genetic variations in CTLA-4, TNF-alpha, and LTA and susceptibility to T-cell lymphoma in a Chinese population. Cancer Epidemiol. 2013;37:930–4.PubMed
41.
Zurück zum Zitat Nasiri H, Farajnia S, Rezamand A, Movassaghpour AA, Esmaeili HA, et al. Genetic variations of tumor necrosis factor -alpha−308 and lymphotoxin-alpha + 252 in Non-Hodgkin Lymphoma and Acute Lymphoblastic Leukemia Patients. Iran J Basic Med Sci. 2013;16:990–5.PubMedPubMedCentral Nasiri H, Farajnia S, Rezamand A, Movassaghpour AA, Esmaeili HA, et al. Genetic variations of tumor necrosis factor -alpha−308 and lymphotoxin-alpha + 252 in Non-Hodgkin Lymphoma and Acute Lymphoblastic Leukemia Patients. Iran J Basic Med Sci. 2013;16:990–5.PubMedPubMedCentral
42.
Zurück zum Zitat Yri OE, Ekstrom PO, Hilden V, Gaudernack G, Liestol K, et al. Influence of polymorphisms in genes encoding immunoregulatory proteins and metabolizing enzymes on susceptibility and outcome in patients with diffuse large B-cell lymphoma treated with rituximab. Leuk Lymphoma. 2013;54:2205–14.PubMed Yri OE, Ekstrom PO, Hilden V, Gaudernack G, Liestol K, et al. Influence of polymorphisms in genes encoding immunoregulatory proteins and metabolizing enzymes on susceptibility and outcome in patients with diffuse large B-cell lymphoma treated with rituximab. Leuk Lymphoma. 2013;54:2205–14.PubMed
43.
Zurück zum Zitat Swartz MK. The PRISMA statement: a guideline for systematic reviews and meta-analyses. J Pediatr Health Care. 2011;25:1–2.PubMed Swartz MK. The PRISMA statement: a guideline for systematic reviews and meta-analyses. J Pediatr Health Care. 2011;25:1–2.PubMed
44.
Zurück zum Zitat Wang SS, Cozen W, Cerhan JR, Colt JS, Morton LM, et al. Immune mechanisms in non-Hodgkin lymphoma: joint effects of the TNF G308A and IL10 T3575A polymorphisms with non-Hodgkin lymphoma risk factors. Cancer Res. 2007;67:5042–54.PubMed Wang SS, Cozen W, Cerhan JR, Colt JS, Morton LM, et al. Immune mechanisms in non-Hodgkin lymphoma: joint effects of the TNF G308A and IL10 T3575A polymorphisms with non-Hodgkin lymphoma risk factors. Cancer Res. 2007;67:5042–54.PubMed
45.
Zurück zum Zitat Morton LM, Wang SS, Cozen W, Linet MS, Chatterjee N, et al. Etiologic heterogeneity among non-Hodgkin lymphoma subtypes. Blood. 2008;112:5150–60.PubMedPubMedCentral Morton LM, Wang SS, Cozen W, Linet MS, Chatterjee N, et al. Etiologic heterogeneity among non-Hodgkin lymphoma subtypes. Blood. 2008;112:5150–60.PubMedPubMedCentral
46.
Zurück zum Zitat Abdou AM, Gao X, Cozen W, Cerhan JR, Rothman N, et al. Human leukocyte antigen (HLA) A1-B8-DR3 (8.1) haplotype, tumor necrosis factor (TNF) G-308A, and risk of non-Hodgkin lymphoma. Leukemia. 2010;24:1055–8.PubMedPubMedCentral Abdou AM, Gao X, Cozen W, Cerhan JR, Rothman N, et al. Human leukocyte antigen (HLA) A1-B8-DR3 (8.1) haplotype, tumor necrosis factor (TNF) G-308A, and risk of non-Hodgkin lymphoma. Leukemia. 2010;24:1055–8.PubMedPubMedCentral
47.
Zurück zum Zitat Chen Y, Zheng T, Lan Q, Foss F, Kim C, et al. Cytokine polymorphisms in Th1/Th2 pathway genes, body mass index, and risk of non-Hodgkin lymphoma. Blood. 2011;117:585–90.PubMedPubMedCentral Chen Y, Zheng T, Lan Q, Foss F, Kim C, et al. Cytokine polymorphisms in Th1/Th2 pathway genes, body mass index, and risk of non-Hodgkin lymphoma. Blood. 2011;117:585–90.PubMedPubMedCentral
48.
Zurück zum Zitat Mainou-Fowler T, Dickinson AM, Taylor PR, Mounter P, Jack F, et al. Tumour necrosis factor gene polymorphisms in lymphoproliferative disease. Leuk Lymphoma. 2000;38:547–52.PubMed Mainou-Fowler T, Dickinson AM, Taylor PR, Mounter P, Jack F, et al. Tumour necrosis factor gene polymorphisms in lymphoproliferative disease. Leuk Lymphoma. 2000;38:547–52.PubMed
49.
Zurück zum Zitat Spink CF, Keen LJ, Mensah FK, Law GR, Bidwell JL, et al. Association between non-Hodgkin lymphoma and haplotypes in the TNF region. Br J Haematol. 2006;133:293–300.PubMed Spink CF, Keen LJ, Mensah FK, Law GR, Bidwell JL, et al. Association between non-Hodgkin lymphoma and haplotypes in the TNF region. Br J Haematol. 2006;133:293–300.PubMed
50.
Zurück zum Zitat Habermann TM, Wang SS, Maurer MJ, Morton LM, Lynch CF, et al. Host immune gene polymorphisms in combination with clinical and demographic factors predict late survival in diffuse large B-cell lymphoma patients in the pre-rituximab era. Blood. 2008;112:2694–702.PubMedPubMedCentral Habermann TM, Wang SS, Maurer MJ, Morton LM, Lynch CF, et al. Host immune gene polymorphisms in combination with clinical and demographic factors predict late survival in diffuse large B-cell lymphoma patients in the pre-rituximab era. Blood. 2008;112:2694–702.PubMedPubMedCentral
51.
Zurück zum Zitat McAulay KA, Haque T, Crawford DH. Tumour necrosis factor gene polymorphism: a predictive factor for the development of post-transplant lymphoproliferative disease. Br J Cancer. 2009;101:1019–27.PubMedPubMedCentral McAulay KA, Haque T, Crawford DH. Tumour necrosis factor gene polymorphism: a predictive factor for the development of post-transplant lymphoproliferative disease. Br J Cancer. 2009;101:1019–27.PubMedPubMedCentral
52.
Zurück zum Zitat Rothman N, Skibola CF, Wang SS, Morgan G, Lan Q, et al. Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the InterLymph Consortium. Lancet Oncol. 2006;7:27–38.PubMed Rothman N, Skibola CF, Wang SS, Morgan G, Lan Q, et al. Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the InterLymph Consortium. Lancet Oncol. 2006;7:27–38.PubMed
53.
Zurück zum Zitat Au WY, Fung A, Wong KF, Chan CH, Liang R. Tumor necrosis factor alpha promoter polymorphism and the risk of chronic lymphocytic leukemia and myeloma in the Chinese population. Leuk Lymphoma. 2006;47:2189–93.PubMed Au WY, Fung A, Wong KF, Chan CH, Liang R. Tumor necrosis factor alpha promoter polymorphism and the risk of chronic lymphocytic leukemia and myeloma in the Chinese population. Leuk Lymphoma. 2006;47:2189–93.PubMed
54.
Zurück zum Zitat Babel N, Vergopoulos A, Trappe RU, Oertel S, Hammer MH, et al. Evidence for genetic susceptibility towards development of posttransplant lymphoproliferative disorder in solid organ recipients. Transplantation. 2007;84:387–91.PubMed Babel N, Vergopoulos A, Trappe RU, Oertel S, Hammer MH, et al. Evidence for genetic susceptibility towards development of posttransplant lymphoproliferative disorder in solid organ recipients. Transplantation. 2007;84:387–91.PubMed
55.
Zurück zum Zitat Takashiba S, Shapira L, Amar S, Van Dyke TE. Cloning and characterization of human TNFα promoter region. Gene. 1993;131:307–8.PubMed Takashiba S, Shapira L, Amar S, Van Dyke TE. Cloning and characterization of human TNFα promoter region. Gene. 1993;131:307–8.PubMed
56.
Zurück zum Zitat Balkwill F. TNF-alpha in promotion and progression of cancer. Cancer Metastasis Rev. 2006;25:409–16.PubMed Balkwill F. TNF-alpha in promotion and progression of cancer. Cancer Metastasis Rev. 2006;25:409–16.PubMed
57.
Zurück zum Zitat Ding B, Fu S, Wang M, Yue C, Wang W, et al. Tumor necrosis factor alpha −308 G>A polymorphisms and cervical cancer risk: a meta-analysis. Int J Gynecol Cancer. 2012;22:213–9.PubMed Ding B, Fu S, Wang M, Yue C, Wang W, et al. Tumor necrosis factor alpha −308 G>A polymorphisms and cervical cancer risk: a meta-analysis. Int J Gynecol Cancer. 2012;22:213–9.PubMed
58.
Zurück zum Zitat Zhang HL, Zhang YJ. A systemic assessment of the association between tumor necrosis factor alpha 308 G/A polymorphism and risk of cervical cancer. Tumour Biol. 2013;34:1659–65.PubMed Zhang HL, Zhang YJ. A systemic assessment of the association between tumor necrosis factor alpha 308 G/A polymorphism and risk of cervical cancer. Tumour Biol. 2013;34:1659–65.PubMed
59.
Zurück zum Zitat Hong Y, Ge Z, Jing C, Shi J, Dong X, et al. Functional promoter −308G>A variant in tumor necrosis factor alpha gene is associated with risk and progression of gastric cancer in a Chinese population. PLoS ONE. 2013;8:e50856.PubMedPubMedCentral Hong Y, Ge Z, Jing C, Shi J, Dong X, et al. Functional promoter −308G>A variant in tumor necrosis factor alpha gene is associated with risk and progression of gastric cancer in a Chinese population. PLoS ONE. 2013;8:e50856.PubMedPubMedCentral
60.
Zurück zum Zitat Fang F, Yao L, Yu XJ, Yu L, Wu Q. TNFalpha −308 G/A polymorphism is associated with breast cancer risk: a meta-analysis involving 10,184 cases and 12,911 controls. Breast Cancer Res Treat. 2010;122:267–71.PubMed Fang F, Yao L, Yu XJ, Yu L, Wu Q. TNFalpha −308 G/A polymorphism is associated with breast cancer risk: a meta-analysis involving 10,184 cases and 12,911 controls. Breast Cancer Res Treat. 2010;122:267–71.PubMed
61.
Zurück zum Zitat Xie L, Liang XN, Deng Y, Qin X, Li S. TNF-alpha-308G/A polymorphisms and nasopharyngeal cancer risk: a meta-analysis. Eur Arch Otorhinolaryngol. 2013;270:1667–72.PubMed Xie L, Liang XN, Deng Y, Qin X, Li S. TNF-alpha-308G/A polymorphisms and nasopharyngeal cancer risk: a meta-analysis. Eur Arch Otorhinolaryngol. 2013;270:1667–72.PubMed
62.
Zurück zum Zitat Azmy IA, Balasubramanian SP, Wilson AG, Stephenson TJ, Cox A, et al. Role of tumour necrosis factor gene polymorphisms (−308 and −238) in breast cancer susceptibility and severity. Breast Cancer Res. 2004;6:R395–400.PubMedPubMedCentral Azmy IA, Balasubramanian SP, Wilson AG, Stephenson TJ, Cox A, et al. Role of tumour necrosis factor gene polymorphisms (−308 and −238) in breast cancer susceptibility and severity. Breast Cancer Res. 2004;6:R395–400.PubMedPubMedCentral
63.
Zurück zum Zitat Gorouhi F, Islami F, Bahrami H, Kamangar F. Tumour-necrosis factor-A polymorphisms and gastric cancer risk: a meta-analysis. Br J Cancer. 2008;98:1443–51.PubMedPubMedCentral Gorouhi F, Islami F, Bahrami H, Kamangar F. Tumour-necrosis factor-A polymorphisms and gastric cancer risk: a meta-analysis. Br J Cancer. 2008;98:1443–51.PubMedPubMedCentral
64.
Zurück zum Zitat Zhou P, Lv GQ, Wang JZ, Li CW, Du LF, et al. The TNF-alpha-238 polymorphism and cancer risk: a meta-analysis. PLoS ONE. 2011;6:e22092.PubMedPubMedCentral Zhou P, Lv GQ, Wang JZ, Li CW, Du LF, et al. The TNF-alpha-238 polymorphism and cancer risk: a meta-analysis. PLoS ONE. 2011;6:e22092.PubMedPubMedCentral
65.
Zurück zum Zitat Yu JY, Li L, Ma H, Liu K, Cheng X, et al. Tumor necrosis factor-alpha 238 G/A polymorphism and gastric cancer risk: a meta-analysis. Tumour Biol. 2013;34:3859–63.PubMed Yu JY, Li L, Ma H, Liu K, Cheng X, et al. Tumor necrosis factor-alpha 238 G/A polymorphism and gastric cancer risk: a meta-analysis. Tumour Biol. 2013;34:3859–63.PubMed
66.
Zurück zum Zitat Cheng K, Zhao YJ, Liu L, Wan JJ. Tumor necrosis factor-alpha 238 G/A polymorphism and risk of hepatocellular carcinoma: evidence from a meta-analysis. Asian Pac J Cancer Prev. 2013;14:3275–9.PubMed Cheng K, Zhao YJ, Liu L, Wan JJ. Tumor necrosis factor-alpha 238 G/A polymorphism and risk of hepatocellular carcinoma: evidence from a meta-analysis. Asian Pac J Cancer Prev. 2013;14:3275–9.PubMed
67.
Zurück zum Zitat Cen G, Wu W. Association between tumor necrosis factor-alpha 857C/T polymorphism and gastric cancer: a meta-analysis. Tumour Biol. 2013;34:3383–8.PubMed Cen G, Wu W. Association between tumor necrosis factor-alpha 857C/T polymorphism and gastric cancer: a meta-analysis. Tumour Biol. 2013;34:3383–8.PubMed
68.
Zurück zum Zitat Conde L, Halperin E, Akers NK, Brown KM, Smedby KE, et al. Genome-wide association study of follicular lymphoma identifies a risk locus at 6p21.32. Nat Genet. 2010;42:661–4.PubMedPubMedCentral Conde L, Halperin E, Akers NK, Brown KM, Smedby KE, et al. Genome-wide association study of follicular lymphoma identifies a risk locus at 6p21.32. Nat Genet. 2010;42:661–4.PubMedPubMedCentral
69.
Zurück zum Zitat Smedby KE, Foo JN, Skibola CF, Darabi H, Conde L, et al. GWAS of follicular lymphoma reveals allelic heterogeneity at 6p21.32 and suggests shared genetic susceptibility with diffuse large B-cell lymphoma. PLoS Genet. 2011;7:e1001378.PubMedPubMedCentral Smedby KE, Foo JN, Skibola CF, Darabi H, Conde L, et al. GWAS of follicular lymphoma reveals allelic heterogeneity at 6p21.32 and suggests shared genetic susceptibility with diffuse large B-cell lymphoma. PLoS Genet. 2011;7:e1001378.PubMedPubMedCentral
70.
Zurück zum Zitat Tan DE, Foo JN, Bei JX, Chang J, Peng R, et al. Genome-wide association study of B cell non-Hodgkin lymphoma identifies 3q27 as a susceptibility locus in the Chinese population. Nat Genet. 2013;45:804–7.PubMed Tan DE, Foo JN, Bei JX, Chang J, Peng R, et al. Genome-wide association study of B cell non-Hodgkin lymphoma identifies 3q27 as a susceptibility locus in the Chinese population. Nat Genet. 2013;45:804–7.PubMed
Metadaten
Titel
The association between the polymorphisms of TNF-α and non-Hodgkin lymphoma: a meta-analysis
verfasst von
Yong-Qiao He
Jin-Hong Zhu
Shao-Yi Huang
Zhuo Cui
Jing He
Wei-Hua Jia
Publikationsdatum
01.12.2014
Verlag
Springer Netherlands
Erschienen in
Tumor Biology / Ausgabe 12/2014
Print ISSN: 1010-4283
Elektronische ISSN: 1423-0380
DOI
https://doi.org/10.1007/s13277-014-2569-6

Weitere Artikel der Ausgabe 12/2014

Tumor Biology 12/2014 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.